Prostate cancer tool may help patients to decide on treatment

Abstract

T he results from a randomized clinical trial have demonstrated that a new decision-making tool can help men with prostate cancer (PCa), together with their medical teams, make choices regarding their treatment that improve their satisfaction with care. According to the researchers, the main goal of Patient Preferences for Prostate Cancer Care (PreProCare), a web-based decision tool, is to align the patient’s treatment options with the degree of risk posed by their disease while remaining in line with the patient’s values, unique needs, and preferences. The researchers believe that this patient-centered care approach reduces fears and regrets about therapy decisions while improving patient satisfaction with the result.